Adam Rudin is an actuarial and healthcare economics executive with 30+ years of experience guiding organizations through some of the most significant shifts in the U.S. healthcare landscape. His work has consistently focused on strengthening financial performance, improving risk accuracy, and enabling care models that deliver better outcomes at lower cost.

Adam has held senior leadership roles across health plans, consulting, and value‑based care, managing teams of 30, owning P&Ls, and partnering directly with large employers and health system leaders. His background spans all core actuarial disciplines, with deep specialization in ACA and Medicare risk adjustment, pricing strategy, forecasting, and enterprise analytics.

During his tenure at McKinsey, Adam helped build the firm’s actuarial capability and served as the lead expert on risk adjustment, advising C‑suite leaders on strategy, operations, and regulatory implications. At Wakely, he focused on strengthening pricing and business strategy for ACA and Medicare Advantage plans.

At Somatus, Adam leads Actuarial and Medical Economics, ensuring that risk arrangements are appropriately priced for CKD and ESRD populations and that the company's value‑based care model delivers measurable clinical and financial impact.

Adam is an FSA, MAAA, and UC Berkeley mathematics graduate, committed to advancing actuarial science as a strategic lever for a more effective and sustainable healthcare system.